Expression of phoenixin-14 and nesfatin-1 in the hypothalamo–pituitary–gonadal axis in the phases of the estrous cycle

MakaleAçık ErişimScopus SJRQ2
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

Phoenixin-14 (PNX-14) and nucleobindin 2 (NUCB2)/nesfatin-1 are regulatory neuropeptides expressed in the hypothalamus. These neuropeptides can be effective in hormonal regulation of the hypothalamo–pituitary–gonadal (HPG) axis and reproductive functions. In the present study, the distribution of PNX-14 and NUCB2/nesfatin-1 in the hypothalamus, pituitary, ovary, and uterus tissues during the phases of the estrous cycle in female rats was investigated. Eighteen Wistar Albino rats determined among animals showing regular estrous cycle by vaginal smear method were divided into three groups: proestrus (Group I), estrus (Group II) and diestrus (Group III). Serum gonadotropin-releasing hormone (GnRH), plasma PNX-14, and NUCB2/nesfatin-1 concentrations were the highest, moderate, and lowest in estrus, diestrus, and proestrus phases, respectively. PNX-14 immunoreactivity in the supraoptic and arcuate nuclei of the hypothalamus and NUCB2/nesfatin-1 immunoreactivity in the paraventricular nuclei were particularly evident in the estrus phase. These neuropeptide immunoreactivities were decreased in different cells of anterior pituitary during proestrus compared with those during estrus and diestrus. PNX-14 immunoreactivity in the ovary, especially during the estrus phase, was diffuse and intense in the granulosa and luteal cells and oocytes, and it was few and weak in theca cells. In addition, NUCB2/nesfatin-1 immunoreactivity was abundant and strong in granulosa and luteal cells, theca and interstitial cells, and oocytes during estrus. In the estrus phase, PNX-14 immunoreactivity was strong in the glandular epithelial cells and stromal cells of the endometrium, also NUCB2/nesfatin-1 immunoreactivity was strong in the epithelial and glandular epithelial cells. As a result, when the estrous cycle was evaluated, it was concluded that the changes in the distribution of PNX-14 and NUCB2/nesfatin-1 at all phases were related to GnRH and that these neuropeptides showed the highest immunoreactivity especially in the HPG axis and uterus tissues of estrus rats.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/munzur/2571Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1016/j.npep.2022.102299Yayıncı resmi DOI adresi
İndeks kayıtları
Kaydın indeks veri tabanlarındaki sayfası (aktarımda alınan kayıt numarasıyla). Erişim, indeksin kendi koşullarına bağlıdır.
Atıflar
Scopus
21
OpenAlex
22
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorParlak Ak, Tuba
dc.contributor.authorYaman, Mine
dc.contributor.authorBayrakdar, Ali
dc.contributor.authorBulmus, Ozgur
dc.date.accessioned2026-10-28T14:55:33.313143699Z
dc.date.available2026-10-28T14:55:33.313143699Z
dc.date.issued2023
dc.description.abstractPhoenixin-14 (PNX-14) and nucleobindin 2 (NUCB2)/nesfatin-1 are regulatory neuropeptides expressed in the hypothalamus. These neuropeptides can be effective in hormonal regulation of the hypothalamo–pituitary–gonadal (HPG) axis and reproductive functions. In the present study, the distribution of PNX-14 and NUCB2/nesfatin-1 in the hypothalamus, pituitary, ovary, and uterus tissues during the phases of the estrous cycle in female rats was investigated. Eighteen Wistar Albino rats determined among animals showing regular estrous cycle by vaginal smear method were divided into three groups: proestrus (Group I), estrus (Group II) and diestrus (Group III). Serum gonadotropin-releasing hormone (GnRH), plasma PNX-14, and NUCB2/nesfatin-1 concentrations were the highest, moderate, and lowest in estrus, diestrus, and proestrus phases, respectively. PNX-14 immunoreactivity in the supraoptic and arcuate nuclei of the hypothalamus and NUCB2/nesfatin-1 immunoreactivity in the paraventricular nuclei were particularly evident in the estrus phase. These neuropeptide immunoreactivities were decreased in different cells of anterior pituitary during proestrus compared with those during estrus and diestrus. PNX-14 immunoreactivity in the ovary, especially during the estrus phase, was diffuse and intense in the granulosa and luteal cells and oocytes, and it was few and weak in theca cells. In addition, NUCB2/nesfatin-1 immunoreactivity was abundant and strong in granulosa and luteal cells, theca and interstitial cells, and oocytes during estrus. In the estrus phase, PNX-14 immunoreactivity was strong in the glandular epithelial cells and stromal cells of the endometrium, also NUCB2/nesfatin-1 immunoreactivity was strong in the epithelial and glandular epithelial cells. As a result, when the estrous cycle was evaluated, it was concluded that the changes in the distribution of PNX-14 and NUCB2/nesfatin-1 at all phases were related to GnRH and that these neuropeptides showed the highest immunoreactivity especially in the HPG axis and uterus tissues of estrus rats.
dc.identifier.articlenumber102299
dc.identifier.doi10.1016/j.npep.2022.102299
dc.identifier.issn0143-4179
dc.identifier.pmid36327662
dc.identifier.scopus2-s2.0-85140961754
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/munzur/2571
dc.identifier.volume97
dc.language.isoen
dc.publisherChurchill Livingstone
dc.relation.ispartofNeuropeptides
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectEstrous cycle
dc.subjectNucleobindin 2 (NUCB2)/nesfatin-1
dc.subjectPhoenixin-14
dc.subjectRat
dc.subject.otherAnimals
dc.subject.otherEstrous Cycle
dc.subject.otherFemale
dc.subject.otherGonadotropin-Releasing Hormone
dc.subject.otherNerve Tissue Proteins
dc.subject.otherNeuropeptides
dc.subject.otherNucleobindins
dc.subject.otherRats
dc.subject.otherRats, Wistar
dc.subject.othercarbon tetrachloride
dc.subject.othergonadorelin
dc.subject.othernesfatin 1
dc.subject.otherneuropeptide
dc.subject.othernucleobindin
dc.subject.otherunclassified drug
dc.subject.othernerve protein
dc.subject.otheranimal experiment
dc.subject.otheranimal model
dc.subject.otherArticle
dc.subject.otherenzyme linked immunosorbent assay
dc.subject.otherestrus cycle
dc.subject.otherhypophysis gonad system
dc.subject.otherhypothalamus hypophysis gonad system
dc.subject.otherimmunohistochemistry
dc.subject.otherimmunoreactivity
dc.subject.othermicroscopy
dc.subject.othernonhuman
dc.subject.otherrat
dc.subject.othervagina smear
dc.subject.otheranimal
dc.subject.othermetabolism
dc.subject.otherWistar rat
dc.titleExpression of phoenixin-14 and nesfatin-1 in the hypothalamo–pituitary–gonadal axis in the phases of the estrous cycle
dc.typeArticle
rdl.citation.openalex22
rdl.citation.scopus21
rdl.oa.statusgreen
rdl.oa.urlhttps://hdl.handle.net/11508/53613
rdl.scopus.quartileQ2
rdl.sdgSDG03
rdl.source.indexSCOPUS